N-butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity
Open Access
- 21 August 2025
- journal article
- Published by Elsevier in Redox Biology
- Vol. 86, 103835
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7252200)
- National Natural Science Foundation of China (82173710)
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2021-I2M-1\u2013028)
This publication has 55 references indexed in Scilit:
- Design, synthesis, and evaluation of n-butylphthalide and ligustrazine hybrids as potent neuroprotective agents for the treatment of ischemic stroke in vitro and in vivoBioorganic Chemistry, 2023
- Could a lipid oxidative biomarker be applied to improve risk stratification in the prevention of cardiovascular disease?Biomedicine & Pharmacotherapy, 2023
- KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potentialMedicinal Research Reviews, 2022
- Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and applicationBiochemical Pharmacology, 2021
- Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implicationsMedicinal Research Reviews, 2021
- Anti-ischemia/reperfusion injury effects of notoginsenoside R1 on small molecule metabolism in rat brain after ischemic stroke as visualized by MALDI–MS imagingBiomedicine & Pharmacotherapy, 2020
- NRF2 and the Hallmarks of CancerCancer Cell, 2018
- dl-3-n-Butylphthalide (NBP) Provides Neuroprotection in the Mice Models After Traumatic Brain Injury via Nrf2-ARE Signaling PathwayNeurochemical Research, 2017
- Drug Affinity Responsive Target Stability (DARTS) for Small-Molecule Target Identification2014
- Mechanisms of TiO2 nanoparticle‐induced neuronal apoptosis in rat primary cultured hippocampal neuronsJournal of Biomedical Materials Research Part A, 2014